Disclosed positions

Estimated from their latest filings — positions may have changed since

$919.3K

combined est. value

Stock	Shares	Price	Value	Weight	As of
XERSXeris Biopharma Holdings, Inc.	113,359	$8.11	$919.3K	100%	2026-06-04

XERS

Xeris Biopharma Holdings, Inc.

$919.3K

113,359 sh

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 0sells 1

Stock	Transaction	Date	~6mo later
XERSXeris Biopharma Holdings, Inc.	Grant — · 24,193 sh	2026-06-04	—
VRNAVerona Pharma plc	Return — · 72,000 sh	2025-10-07	—
VRNAVerona Pharma plc	Exercise — · 72,000 sh	2025-10-07	—
VRNAVerona Pharma plc	Return — · 23,176 sh	2025-10-07	—
VRNAVerona Pharma plc	Sell $10.8K · 824 sh	2025-08-01	—
VRNAVerona Pharma plc	Exercise — · 24,000 sh	2025-08-01	—

XERSGrant

2026-06-04 · Xeris Biopharma Holdings, Inc.

24,193

—

VRNAReturn

2025-10-07 · Verona Pharma plc

72,000

—

VRNAExercise

2025-10-07 · Verona Pharma plc

72,000

—

VRNAReturn

2025-10-07 · Verona Pharma plc

23,176

—

VRNASell

2025-08-01 · Verona Pharma plc

$10.8K

—

VRNAExercise

2025-08-01 · Verona Pharma plc

24,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.